|
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| archive_file = File:AXA-2025-FY-Earnings_presentation.md
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
=== Full Year 2025 earnings presentation ===
* ''AXA Full Year 2025'' earnings presentation delivered on February Earnings26, Presentation2026 <sup>p. 1</sup>
* February 26, 2026 <sup>p. 1</sup>
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
* '''Forward-looking statements''': This presentation contains statements that areinclude predictions of or indicate future events, trends, plans, expectations, or objectives. Theybased are identified by words likeon Management'expects',s 'anticipates',current 'may',views 'plan,'and 'target',subject orto conditional verbs like 'would' and 'could'change <sup>p. 2</sup>.
** A''Expected specific example is the statement regarding expected underlying earnings per share (UEPS) growth'' for 2026, which is provided as one-off guidance forin the context of the final year of the Group's current strategic plan <sup>p. 2</sup>.
** These''Risk statementsfactors'' areand baseduncertainties onthat managementmay affect AXA's current views andbusiness are subjectdescribed toin change.Part They5 involve"Risk knownFactors and unknownRisk risks and uncertainties, many outsideManagement" of AXA's control, which could cause actual results2024 toUniversal differRegistration materiallyDocument <sup>p. 2</sup>.
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
** For a description of important risk factors, refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>.
** AXAAPMs disclaimsare anydefined obligationunder toESMA publiclyguidelines updateand orthe reviseAMF's these2015 statementsposition statement, exceptwith asreconciliations provided in AXA's required2025 byActivity lawReport <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
* '''Non-GAAP financial measures''': The presentation uses certain non-GAAP financial measures, or alternative performance measures (APMs), to analyze operating trends and financial performance <sup>p. 2</sup>.
** These measures may not be comparable to those used by other companies and should not be considered a substitute for IFRS financial statements <sup>p. 2</sup>.
** Examples of APMs include "Underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing", as defined by ESMA guidelines and the AMF's 2015 position statement <sup>p. 2</sup>.
** Reconciliation of these APMs to IFRS measures can be found in AXA's 2025 Activity Report, with further details in the Glossary <sup>p. 2</sup>.
* '''Document availability''': AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* '''Financial statement status''': The consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to the completion of an audit by statutory auditors <sup>p. 2</sup>.
* The presentation is titled "Full Year 2025 Earnings" <sup>p. 2</sup>.
=== Table of contents ===
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on p.04 <sup>p. 3, 4</sup>.
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on p.09 <sup>p. 3, 9</sup>.
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on p.13 <sup>p. 3, 13</sup>.
== FY25 Highlights ==
* PresentedSection divider slide for ''FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
=== Full Year 2025 | Excellent performance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 keyKey financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | EUR billion unless otherwise mentionedMetric
! class="col-m" style="text-align:right" | MetricValue
! class="col-m" style="text-align:right" | Value / Change
|-
| style="text-align:left" | —Revenues growth vs. FY24
| class="col-m" style="text-align:right" | Revenues+6%
| class="col-m" style="text-align:right" | +6% vs. FY24
|-
| style="text-align:left" | —Underlying EPS growth vs. FY24
| class="col-m" style="text-align:right" | Underlying EPS+8%
| class="col-m" style="text-align:right" | +8% vs. FY24
|-
| style="text-align:left" | —Return on equity
| class="col-m" style="text-align:right" | ROE (FY25)16%
| class="col-m" style="text-align:right" | 16%
|-
| style="text-align:left" | —Solvency II ratio
| class="col-m" style="text-align:right" | Solvency II ratio (FY25)224%
| class="col-m" style="text-align:right" | 224%
|-
| style="text-align:left" | —DPS growth
| class="col-m" style="text-align:right" | Dividend per Share (DPS) growth+8%
|-
| class="col-m" style="text-align:right" | +8%
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | —Underlying EPS outlook for 2026
| class="col-m" style="text-align:right" | AnnualUpper end of 6%-8% sharetarget buybackrange
| class="col-m" style="text-align:right" | 1.25
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026 <sup>p. 5</sup>
* ¹DividendShare isbuyback basedapproved onby the proposal by AXA's Board of Directors on February 25, 2026, and is subjectexpected to approvalcommence byas thesoon Shareholders'as Annualreasonably Generalpracticable, Meetingsubject on April 30, 2026to <sup>p.market 5</sup>conditions
* ²Share buyback follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>
=== Executing the plan on growth, margin and efficiency ===
{| class="wikitable fintable"
|+ Underlying earnings, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (constant FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
| style="text-align:right" | +9%
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
* '''Underlying earnings''' +6% <sup>p. 6</sup>
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* '''High organic growth''': +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup>
* Scaling the business: Continued investments in growth and technology
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>
=== Diversified franchise, well positioned in an attractive industry ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
* '''Secular trends fueling demand across businesses''' <sup>p. 7</sup>
** Protection''Secular trends'' fuel demand across businesses, driven by protection gaps and emerging corporate risks, (relevantas forwell SMEas &demographics Mid-marketdriving anddemand Largefor &private Specialtyretirement segments) <sup>p.and 7</sup>healthcare
* ''Our right to win'' is supported by four strategic pillars:
** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup>
** Leading brand & high customer NPS
* '''Our right to win''' <sup>p. 7</sup>
** Strong and diversified distribution
** Leading brand & high customer NPS <sup>p. 7</sup>
** Technical expertise to price & underwrite risks
** Strong and diversified distribution <sup>p. 7</sup>
** Scale offering cost advantage
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
=== Laying the foundation for the next plan ===
* ''Strategic pillars'' established to lay the foundation for the next plan:
* (icon) '''Clear tech and AI roadmap''' <sup>p. 8</sup>
* (icon)* '''DrivingClear efficiency'tech'' and AI roadmap <sup>p. 8</sup>
** (icon)''Driving efficiency'''Enhancing capitalacross allocation discipline'''operations <sup>p. 8</sup>
* (icon)* '''BuildingEnhancing resilience'capital'' allocation discipline <sup>p. 8</sup>
** Confidence''Building inresilience'' sustainingacross earningsthe growthbusiness <sup>p. 8</sup>
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
== FY25 Business Performance ==
=== FY25 business performance ===
* Guillaume Borie <sup>p. 9</sup>
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
=== Strong delivery across our businesses ===
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ KeyGross metricswritten premiums and underlying earnings by geographyregion FY25 <sup>p. 10</sup>
! style="text-align:left" | EURRegion billion(share unlessof otherwisetotal mentionedGWP¹)
! class="col-sm" style="text-align:right" | %Gross ofwritten total GWPpremiums
! class="col-sm" style="text-align:right" | GrossUnderlying written premiumsearnings
! class="col-s" style="text-align:right" | GWP change
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | UE change
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | 27+6% to EUR 31bn
| class="col-m" style="text-align:right" | 31+7% to EUR 2.2bn
| style="text-align:right" | +6%
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | 38+6% to EUR 43bn
| class="col-m" style="text-align:right" | 43+9% to EUR 3.5bn
| style="text-align:right" | +6%
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | 17+4% to EUR 19bn
| class="col-m" style="text-align:right" | 19+9% to EUR 1.9bn
| style="text-align:right" | +4%
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | 18+13% to EUR 20bn
| class="col-m" style="text-align:right" | 20+6% to EUR 1.5bn
| style="text-align:right" | +13%
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
|}
</div>
* A checkmark icon is displayed next to each business segment's results <sup>p. 10</sup>.
* Footnotes: Changes for Gross written premiums are at constant scope and FX; changes for underlying earnings are at constant FX. The total GWP base for FY25 excludes AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
=== P&C | Strong margins, confidence in sustaining growth ===
* ''Gross written premiums'' (GWP) reached EUR 58bn <sup>p. 11</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
{| class="wikitable fintable"
|+** AXA XL GWP splitincludes byAXA segmentXL Re premiums of EUR 2.6bn <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
! style="text-align:left" | Segment
* ''Retail and SME & Mid-market'' strategic outlook:
! class="col-s" style="text-align:right" | Share
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>.
|-
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
| style="text-align:left" | Retail
* ''AXA XL (Large & Specialty)'' strategic outlook:
| style="text-align:right" | 34%
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>.
|-
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
| style="text-align:left" | SME & Mid-market
* ''Earnings drivers'' supporting performance:
| style="text-align:right" | 33%
|-
| style="text-align:left" | AXA XL (Large & Specialty)
| style="text-align:right" | 33%
|}
</div>
* '''Underlying earnings''' +9% to EUR 5.9bn (FY25 vs. FY24 at constant FX) <sup>p. 11</sup>.
* AXA XL (Large & Specialty) includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>.
* '''Strategic priorities for 2025''' <sup>p. 11</sup>:
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins <sup>p. 11</sup>.
** '''AXA XL (Large & Specialty)''': Profitable growth with stable margins <sup>p. 11</sup>.
* '''Strategic priorities beyond 2025''' <sup>p. 11</sup>:
** '''Retail and SME & Mid-market''': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
** '''AXA XL (Large & Specialty)''': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* '''Additional drivers''' supporting growth include <sup>p. 11</sup>:
** Continued progress on efficiency <sup>p. 11</sup>.
** Higher investment income <sup>p. 11</sup>.
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
* (donut chart) '''GWP''' of EUR 58bn, with the following segment mix <sup>p. 11</sup>:
=== L&H | Good momentum, well positioned to capture growth opportunities ===
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
{| class="wikitable fintable"
|* ''Underlying earnings'' +7% GWPLFL splitto byEUR business3.5bn type(change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
! style="text-align:left" | Business type
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
! class="col-s" style="text-align:right" | Share
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
|-
* ''Short-term business'' strategic priorities:
| style="text-align:left" | Long-term
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
| style="text-align:right" | 70%
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
|-
* ''Strategic levers'' for growth and efficiency:
| style="text-align:left" | Short-term
| style="text-align:right" | 30%
|}
</div>
* '''Underlying earnings''' +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* '''Strategic priorities for 2025''':
** '''Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
** '''Short-term business''': Growing technical results while absorbing the Mexico VAT impact <sup>p. 12</sup>.
* '''Strategic priorities beyond 2025''':
** '''Long-term business''': Capturing savings & retirement opportunities and sourcing the best asset management products for customers <sup>p. 12</sup>.
** '''Short-term business''': Capitalizing on demand for health & protection while further improving margins <sup>p. 12</sup>.
* '''Additional strategic initiatives''':
** Focus on cost reduction <sup>p. 12</sup>.
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage and& improve customer outcomes in Health <sup>p. 12</sup>.
* (donut) '''GWP''' of EUR 57bn, split between Long-term (70%) and Short-term (30%) business <sup>p. 12</sup>.
== FY25 Financial Performance ==
=== FY25 financial performance ===
* FY25 Financial Performance <sup>p. 13</sup>
* Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
=== P&C | Continued disciplined growth ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues breakdownby segment, FY25FY24 vs FY24FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Pricingo/w effectpricing
! class="col-s" style="text-align:right" | Volumeo/w effectvolume
|-
| style="text-align:left" | Commercial lines
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | '''Total'''
| style="text-align:right; font-weight:bold" | '''56.5'''
| style="text-align:right; font-weight:bold" | '''58.0'''
| style="text-align:right; font-weight:bold" | '''+5%'''
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|}
</div>
* Commercial lines: Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>.
* Commercial lines: Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>.
* AXA XL Reinsurance: Growth supported by alternative capital <sup>p. 14</sup>.
* Retail lines: Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>.
* All changes are at constant scope and FX. "Pricing" refers to price effect. "Volume" includes exposure adjustments and mix & other effects <sup>p. 14</sup>.
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio componentsbridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | RatioCombined (%)ratio
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | '''CombinedTotal combined ratio'''
| style="text-align:right; font-weight:bold" | '''91.0%'''
| style="text-align:right; font-weight:bold" | '''90.6%'''
|}
</div>
* AUndiscounted better '''undiscounted current yearCY loss ratio''' (excludingex Nat Cat) wasimproved driven byfrom: <sup>p. 15</sup>
** Margin expansion in Commercial lines SME & mid-market business and Personal lines, reflecting a favorable pricing environment <sup>p. 15</sup>.
** Stable AXA XL Insurance margins at attractive levels, reflecting disciplined cycle management <sup>p. 15</sup>.
* The '''expenseExpense ratio''' improved, reflecting the impact of efficiency measures, while the company continuedcontinuing to invest in growth initiatives and technology <sup>p. 15</sup>.
* '''Nat Cat charges''' were below the normalized load <sup>p. 15</sup>.
* There was a '''lower reliance''' on priorPrior year reserve development <sup>p.shows 15</sup>.lower reliance
* TheReserve companyprudence isenhanced by taking advantage of a good year to '''enhance reserve prudence''' <sup>p. 15</sup>.
=== P&C | Earnings growth from higher underwriting and financial result ===
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m.
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* The above two components form the "Underwriting result," which includes expenses <sup>p. 16</sup>.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* The above two components form the "Financial result" <sup>p. 16</sup>.
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance.
* Better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence <sup>p. 16</sup>.
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR.
* Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>.
* Higher unwind of discount of claims reserves was in line with guidance <sup>p. 16</sup>.
* An unfavorable forex impact was recorded, notably due to USD depreciation vs. EUR <sup>p. 16</sup>.
* (waterfall) '''Underlying earnings''' bridge FY24 to FY25 (in EUR million, at constant FX): EUR 5,510m → EUR 5,872m (+9%) <sup>p. 16</sup>
=== Life & Health | Strong growth in premiums, positive net flows ===
* All figures are in EUR billion. All changes are at constant scope and FX <sup>p. 17</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP &and other revenues by line, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
| style="text-align:right" | -7%
|-
| style="text-align:left" | '''Total'''Health GWP
| style="text-align:right" | '''3417.5'''
| style="text-align:right" | '''3719.5'''0
| style="text-align:right" | '''+95%'''
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Individual
| style="text-align:right" | +4%
|-
| style="text-align:left" | '''Total'''Employee Benefits GWP
| style="text-align:right" | '''17.5'''—
| style="text-align:right" | '''1912.0'''9
| style="text-align:right" | '''+54%'''
|}
</div>
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | +2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|-
| style="text-align:left" | '''Total'''
| style="text-align:right" | '''+1.5'''
| style="text-align:right" | '''+5.4'''
|}
</div>
* '''FY25 Employee Benefits''' GWP and other revenues were EUR 12.9bn (+4% vs. FY24), including both short-term and long-term benefits <sup>p. 17</sup>.
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
* All figures are in EUR billion and changes are at constant scope and FX. <sup>p. 18</sup>
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. <sup>p. 18</sup>
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits. <sup>p. 18</sup>
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. <sup>p. 18</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ KeyPVEP valuetrend metricsby segment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | '''Total PVEP'''
| style="text-align:right; font-weight:bold" | '''50.9'''
| style="text-align:right; font-weight:bold" | '''49.4'''
| style="text-align:right; font-weight:bold" | '''-2%'''
|-
| style="text-align:left" | Protection & Health
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''NB CSM (pre-tax)'''
| style="text-align:right" | '''2.2'''
| style="text-align:right" | '''2.2'''
| style="text-align:right" | '''+3%'''
|-
| style="text-align:left" | '''NBV (post-tax)'''
| style="text-align:right" | '''2.3'''
| style="text-align:right" | '''2.2'''
| style="text-align:right" | '''stable'''
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual Service Margin (CSM) rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | CSMValue
! class="col-s" style="text-align:right" | Life CSM
! class="col-s" style="text-align:right" | Health CSM
|-
| style="text-align:left" | '''FY24'''
| style="text-align:right" | '''33.6'''
| style="text-align:right" | '''25.8'''
| style="text-align:right" | '''7.7'''
|-
| style="text-align:left" | New business CSM
| style="text-align:right" | +2.2
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying return on in-force
| style="text-align:right" | +1.3
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | CSM release
| style="text-align:right" | -3.0
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Economic variance
| style="text-align:right" | +0.6
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.3
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | -1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''FY25'''
| style="text-align:right" | '''33.0'''
| style="text-align:right" | '''25.4'''
| style="text-align:right" | '''7.6'''
|}
</div>
* '''Normalized CSM''' increased by +2% at constant scope and FX; CSM release growth reflects better margins, while new business CSM growth was impacted by higher rates <sup>p. 19</sup>.
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
* '''Economic variance''' reflects tightening government spreads and positive equity market returns <sup>p. 19</sup>.
* '''OperatingEconomic variance''' wasreflecting drivengovernment byspreads better marginstightening and netpositive flows,equity whichmarket were more than offset by a reduction in the duration of Group Life business in Switzerlandreturns <sup>p. 19</sup>.
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* '''FX impact''' was mainly from JPY and HKD depreciation <sup>p. 19</sup>.
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings walk by componentbridge, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | 415
| style="text-align:right" | 479
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | 2,680
| style="text-align:right" | 2,804
|-
| style="text-align:left" | Financial result
| style="text-align:right" | 975
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax & others
| style="text-align:right" | -748
| style="text-align:right" | -728
|-
| style="text-align:left" | '''Total Underlying earnings'''
| style="text-align:right" | '''3,323'''
| style="text-align:right" | '''3,501'''
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings walk, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
<div style="overflow-x:auto">
* ''Short-term technical margin'': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>
{| class="wikitable fintable"
|+* Underlying''Long-term earningsresult'' byincl. segmentCSM release: EUR 2,680m in FY24 vsto EUR 2,804m in FY25 <sup>p. 20</sup>
* ''Financial result'': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR billion
* ''Tax & others'': EUR -748m in FY24 to EUR -728m in FY25 <sup>p. 20</sup>
! class="col-s" style="text-align:right" | FY24
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup>
! class="col-s" style="text-align:right" | FY25
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup>
! class="col-s" style="text-align:right" | Change vs. FY24
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
|-
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
| style="text-align:left" | Life
| style="text-align:right" | 2.6
| style="text-align:right" | 2.7
| style="text-align:right" | +4%
|-
| style="text-align:left" | Health
| style="text-align:right" | 0.7
| style="text-align:right" | 0.8
| style="text-align:right" | +17%
|}
</div>
* Strong '''short-term technical margin''' reflects underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>.
* Higher '''long-term results''' from an increase in CSM release (+8%), reflecting growth in the reserve base, including from favorable equity market performance and better margins <sup>p. 20</sup>.
* (waterfall) '''Underlying earnings''' +7% at constant FX, from EUR 3,323m in FY24 to EUR 3,501m in FY25 <sup>p. 20</sup>.
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GroupEarnings earningsand summary,net income breakdown FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | —-
|-
| style="text-align:left" | '''Total underlyingUnderlying earnings'''
| style="text-align:right" | '''8.1'''
| style="text-align:right" | '''8.4'''
| style="text-align:right" | '''+6%'''
|-
| style="text-align:left" | '''Net income reconciliation'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total netNet income'''
| style="text-align:right" | '''7.9'''
| style="text-align:right" | '''9.8'''
| style="text-align:right" | '''+26%'''
|}
</div>
* Of which capital gains from AXA IM disposal: FY25 EUR +2.2bn <sup>p. 21</sup>
* Commentary on '''underlying earnings''':
** Driven by strong performance from insurance businesses <sup>p. 21</sup>.
** Stable holding cost is expected to remain at the current level in 2026 <sup>p. 21</sup>.
* Commentary on '''net income''':
** Higher net income mainly reflects higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>.
** Lower financial flows reflect unfavorable forex impact <sup>p. 21</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share bridge, FY24 vsto FY25 <sup>p. 21</sup>
! style="text-align:left" | EuroEUR
! class="col-s" style="text-align:right" | FY24Underlying earnings per share
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings per shareFY24
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
|}
</div>
* Drivers of change:
** +6% from earnings growth <sup>p. 21</sup>
** +3% from capital management <sup>p. 21</sup>
** -2% from forex, which includes -1% from temporary earnings dilution from the AXA IM sale due to the timing of the anti-dilutive share buyback <sup>p. 21</sup>
* Change for underlying earnings and net income is at constant FX; change for underlying earnings per share is on a reported basis <sup>p. 21</sup>.
=== Shareholders' Equity ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity and key ratios <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Shareholders'Earnings equity (Group share)growth
| style="text-align:right" | 49.9+6%
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHECapital (excl. OCI)management
| style="text-align:right" | 58.0+3%
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCIForex
| style="text-align:right" | -8.12%
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHETemporary (excl.earnings OCIdilution &from undatedAXA subordinatedIM debt)sale
| style="text-align:right" | 53.2-1%
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearingFY25
| style="text-align:right" | 203.6%86
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
* ''Underlying earnings'' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
=== Shareholders' equity ===
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity reconciliationroll-forward <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | '''Opening Shareholders' equity'''
| style="text-align:right" | '''49.9'''
| style="text-align:right" | '''45.5'''
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +1.3
| style="text-align:right" | +0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | +9.8
| style="text-align:right" | +5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | —-
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | —-
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | +0.3
|-
| style="text-align:left" | '''Closing Shareholders' equity'''
| style="text-align:right" | '''47.2'''
| style="text-align:right" | '''47.2'''
|}
</div>
* Footnote: Shareholders' equity is Group share <sup>p. 22</sup>.
* All figures are in EUR billion <sup>p. 22</sup>.
=== Higher organic cash remittance and robust cash position at Holding ===
* (bar) ''Net cash remittance'' trend:
<div style="overflow-x:auto">
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
{| class="wikitable fintable"
|+** Net''FY25'': cashEUR remittance7.5bn and holding cash position walk, FY24-FY25total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Ordinary remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Proceeds from in-force treaties
| style="text-align:right" | 0.6
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total net cash remittance'''
| style="text-align:right" | '''7.7'''
| style="text-align:right" | '''7.5'''
|-
| style="text-align:left" | Remittance ratio (%)
| style="text-align:right" | 82%
| style="text-align:right" | 82%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Holding cash position walk—
|-
| style="text-align:left" | '''FY24 Cash position'''
| style="text-align:right" | '''4.0'''
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:right" | +3.1
|-
| style="text-align:left" | '''FY25 Cash position'''
| style="text-align:right" | '''5.6'''
|}
</div>
* The EUR 0.6bn proceeds are related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.
* Remittance ratio is based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25.
* All figures in EUR billion <sup>p. 23</sup>.
=== Solvency II at 224% ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II walk from, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | EOF
! class="col-s" style="text-align:right" | SCR
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
|-
| style="text-align:left" | '''FY24'''
| style="text-align:right" | '''216'''55.9
| style="text-align:right" | '''5525.9'''
| style="text-align:right" | '''25.9'''216
|-
| style="text-align:left" | Regulatory & model changes
| style="text-align:right" | +0
| style="text-align:right" | +0.2
| style="text-align:right" | 0.0
| style="text-align:right" | +0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +28
| style="text-align:right" | +8.8
| style="text-align:right" | +0.6
| style="text-align:right" | +28
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -1
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | +4
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -24
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | +2
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
| style="text-align:right" | +2
|-
| style="text-align:left" | '''FY25'''
| style="text-align:right" | '''224'''56.4
| style="text-align:right" | '''5625.4'''2
| style="text-align:right" | '''25.2'''224
|}
</div>
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities onof Solvency II ratio (224%as atof DecDecember 31, 2025 (base 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
| style="text-align:right" | -1
|-
| style="text-align:left" | Euro Sovereign spreads +50bps (1)
| style="text-align:right" | -7
|-
| style="text-align:left" | Credit migration (2)
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
</div>
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Dividend & annual share buyback for EOF comprises foreseeable dividends of EUR -4.8bn and a provision for the 2026 annual share buyback of EUR -1.25bn.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
* '''Footnote 1''': Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* '''Footnote 2''': Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio evolution to 1Q27impacts <sup>p. 25</sup>
! style="text-align:left" | —Event
! class="col-s" style="text-align:right" | SolvencyImpact II ratio(pts)
|-
| style="text-align:left" | '''AsSolvency II ratio as of December 31/12/, 2025'''
| style="text-align:right" | '''224%'''
|-
| style="text-align:left" | ImpactGrandfathering ofend grandfatheringimpact period endon (JanJanuary 1, 2026)
| style="text-align:right" | -10 pts
|-
| style="text-align:left" | '''AsSolvency ofII 01/01/2026'''revision impact to come into effect in 1Q27
| style="text-align:right" | '''215%'''+17
|-
| style="text-align:left" | Impact of Solvency II revision (effective 1Q27)
| style="text-align:right" | +17 pts
|}
</div>
* The end of the grandfathering period is driven by EUR 2.4bn in grandfathered debt is no longer being eligible as capital from thatJanuary 1, date2026.
* No change is expected in organic capital generation from the Solvency II revision.
* The revision providesProvides additional capital flexibility.
* The impact is estimatedEstimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on thatthe same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
=== Thomas Buberl, Group CEO conclusion ===
* ''Section divider'' for the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
* Conclusion <sup>p. 26</sup>
* Thomas Buberl, Group CEO <sup>p. 26</sup>
=== Conclusion ===
* '''Record results''', achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* ''All businesses'' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''', well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* ''Laying foundations'' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* ''Q&A session'' for the Full Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
* Full Year 2025 Earnings <sup>p. 28</sup>
* February 26, 2026 <sup>p. 28</sup>
=== AXA Investor Relations | Keep in touch ===
* ''Investor Relations contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* ''Follow us'': www.axa.com <sup>p. 29</sup>
<div style="overflow-x:auto">
{| class="wikitable"
|+ UpcomingMeet eventsour andmanagement contactevent informationschedule <sup>p. 29</sup>
! style="text-align:left" | Date
! class="col-m" style="text-align:right" | Event
|}
</div>
* '''Contact us''' <sup>p. 29</sup>
** '''Investor Relations phone''': +33 1 40 75 48 42 <sup>p. 29</sup>
** '''Investor Relations email''': investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''' <sup>p. 29</sup>
** '''Website''': www.axa.com <sup>p. 29</sup>
** Social media channels include YouTube, Facebook, Instagram, Twitter, and LinkedIn <sup>p. 29</sup>
* '''Meet our management (upcoming events)''' <sup>p. 29</sup>
* '''March''': Roadshows in Europe and US <sup>p. 29</sup>
== Appendices ==
* Section divider for ''Appendices'' <sup>p. 30</sup>
=== Table of contents ===
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* Additional P&C disclosures <sup>p. 36</sup>
* Additional''Debt IFRS17and disclosuresInvested Assets'' <sup>p. 4131</sup>
* Sustainability''Additional P&C disclosures'' <sup>p. 4436</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
All figures in EUR billion. <sup>p. 32</sup>
=== Gross financial debt ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross financial debt composition <sup>p. 32</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1,1st 2026
|-
| style="text-align:left" | SeniorTier debt1
| style="text-align:right" | 4.8
| style="text-align:right" | 4.6
| style="text-align:right" | 11.3
|-
| style="text-align:left" | TierSenior 1debt
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:left; font-weight:bold" | '''Total'''
| style="text-align:right; font-weight:bold" | '''19.2'''
| style="text-align:right; font-weight:bold" | '''20.3'''
| style="text-align:right; font-weight:bold" | '''20.3'''
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
* '''Debt gearing''': 20.6% for FY24, 22.3% for FY25 <sup>p. 32</sup>
* An annotation notes "o/w €0.4bn redeemed in Jan 2026" <sup>p. 32</sup>
=== Contractual maturity breakdown ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ MaturityContractual profilematurity of gross financial debtbreakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | TotalTier 1
! class="col-s" style="text-align:right" | o/wTier Grandfathered2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | '''Tier 1'''2028
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2025
| style="text-align:right" | 0.5
| style="text-align:right" | —
|-
| style="text-align:left" | 20282030
| style="text-align:right" | 0.5
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | 0.7—
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 010.28
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
| style="text-align:right" | 1.4
|-
| style="text-align:left" | '''TierGrandfathered 2'''debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2026Tier 1 Undated
| style="text-align:right" | 01.94
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | 0.9
| style="text-align:right" | 0.7
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 1.5
| style="text-align:right" | —
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 10.8
| style="text-align:right" | 0.2
|-
| style="text-align:left" | Undated
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | '''SeniorTier debt'''2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | —0.2
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | —
|}
</div>
=== Economic maturity breakdown ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ MaturityEconomic profilematurity by instrument typebreakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
! class="col-s" style="text-align:right" | Total
|-
| style="text-align:left" | 20252026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2026
| style="text-align:right" | —
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2027
| style="text-align:right" | 2.4
| style="text-align:right" | —
| style="text-align:right" | 2.4
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | ~0.4
| style="text-align:right" | —
| style="text-align:right" | ~0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 2.0
| style="text-align:right" | —
| style="text-align:right" | 2.0
|-
| style="text-align:left" | 2030
| style="text-align:right" | ~0.2
| style="text-align:right" | 0.7
| style="text-align:right" | —
| style="text-align:right" | ~0.97
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
| style="text-align:right" | 6.4
| style="text-align:right" | -0.4
| style="text-align:right" | 7.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.5
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | —4.0
| style="text-align:right" | 0.7
| style="text-align:right" | 4.0
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ o/w Grandfathered debt by economic maturity <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | 2026
! class="col-s" style="text-align:right" | 2028
! class="col-s" style="text-align:right" | 2030
! class="col-s" style="text-align:right" | 2031-2039
! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" | TierGrandfathered 1debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 0.8—
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 21 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
</div>
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
=== Footnotes ===
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
=== General account invested assets ===
* 1. Nominal debt <sup>p. 32</sup>
* 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
* 3. Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for this diagram. This should not be construed as an indication that the instrument will not be called for redemption when callable, as such decisions depend on capital, liquidity, and refinancing economics at the time <sup>p. 32</sup>
===* ''Total General Account'' invested assets ===at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ General Account investedInvested assets breakdown, FY25 <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | Share of total%
|-
| style="text-align:left" | '''Fixed income'''
| style="text-align:right" | '''345'''
| style="text-align:right" | '''77%'''
|-
| style="text-align:left" | ''o/w Government bonds''
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | '''41'''
| style="text-align:right" | '''9%'''
|-
| style="text-align:left" | '''PrivateInfrastructure equity and hedge funds'''
| style="text-align:right" | '''23'''10
| style="text-align:right" | '''52%'''
|-
| style="text-align:left" | '''Cash'Listed equities''
| style="text-align:right" | '''19'''10
| style="text-align:right" | '''42%'''
|-
| style="text-align:left" | '''InfrastructurePrivate equity' and hedge funds''
| style="text-align:right" | '''10'''23
| style="text-align:right" | '''25%'''
|-
| style="text-align:left" | '''Listed equities'Cash''
| style="text-align:right" | '''10'''19
| style="text-align:right" | '''24%'''
|-
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | '''2'''
| style="text-align:right" | '''0%'''
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
|}
</div>
* FY25 Total General Account invested assets: EUR 450bn, with a duration gap of -0.4 year.
* Other fixed income (EUR 56bn) includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn).
* Listed equities figure (EUR 10bn) includes hedges; excluding hedges, the value is EUR 14bn.
* Private equity and hedge funds (EUR 23bn) includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn).
* A note indicates to refer to the financial supplement for more details.
=== Structured and Privateprivate Creditcredit assets ===
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and private credit assets inbreakdown the General Account (G/A) portfolioFY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | NotesComments
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | 91% senior CLOs (~40% subordination); 100% AAA-A rated (92% AAA-AA).
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | Incl.- EUR 6bn Dutch mortgages, NHG- guaranteed (Dutch) and- EUR 10bn self- originated mortgages in CHSwitzerland (56% LTV) &and DEGermany (45% LTV).
|-
| style="text-align:left" | Mid-MarketCLO lending& ABS
| style="text-align:right" | 1025
| style="text-align:right" | 26%
| style="text-align:right" | EUR- 8m91% averagesenior ticketCLOs size;with viacirca SMAs40% withsubordination (100% rated AAA-A and 92% strictrated underwriting.AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, and Transport.)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | Mainly- Strong sector diversification (mainly logistics, residential, and retail;), mostly in Europe;, and circa ~60% LTV.
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% is participating.
|}
</div>
* Footnote: G/A stands for General Account.
* Skewed towards resilient industries such as Telecom, Utilities, and Transport <sup>p. 34</sup>.
* Features strong sector diversification, mainly in logistics, residential, and retail <sup>p. 34</sup>.
* Investments are made through Separately Managed Accounts (SMAs) with strict underwriting guidelines, including senior secured status, covenants, and restrictions on asset sales and sector allocation <sup>p. 34</sup>.
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
=== Investment portfolio | Fixed Income reinvestment ===
=== Investment portfolio | Fixed income reinvestment ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ReinvestmentFY25 breakdownFixed byIncome Reinvestment asset class, FY25mix <sup>p. 35</sup>
! style="text-align:left" | Asset classmix
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 fixedFixed incomeIncome reinvestmentReinvestment yieldYield <sup>p. 35</sup>
! style="text-align:left" | Fixed incomeIncome typeType
! class="col-s" style="text-align:right" | Yield
|-
</div>
* Total FY25 fixedFixed income reinvestment oftotaled EUR 5757bn billion,in invested at an average yield of 3.9% with an average duration of 9 yearsFY25 <sup>p. 35</sup>.
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
* The reinvestment includes EUR 19.7 billion of Private & Structured Credit invested at 4.7%, which comprises CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>.
** Average duration of 9 years <sup>p. 35</sup>
* A gradual shift is occurring from alternative total return assets to Private & Structured credit <sup>p. 35</sup>.
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>
* ¹ Footnote: Government and Corporate bonds and related <sup>p. 35</sup>.
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* ² Footnote: Private & Structured credit includes CLOs, ABS, Infra & CRE debt, Fund financing, and Private hybrid <sup>p. 35</sup>.
=== Table of contents ===
<div style="overflow-x:auto">
{| class="wikitable"
|+* Appendix''Debt tableand ofInvested contentsAssets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
! style="text-align:left" | Section
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
! class="col-m" style="text-align:right" | Title
* ''Sustainability'' on page 44 <sup>p. 36</sup>
! class="col-xs" style="text-align:right" | Page
|-
| style="text-align:left" | 1
| class="col-m" style="text-align:right" | Debt and Invested Assets
| class="col-xs" style="text-align:right" | 31
|-
| style="text-align:left" | 2
| class="col-m" style="text-align:right" | Additional P&C disclosures
| class="col-xs" style="text-align:right" | 36
|-
| style="text-align:left" | 3
| class="col-m" style="text-align:right" | Additional IFRS17 disclosures
| class="col-xs" style="text-align:right" | 41
|-
| style="text-align:left" | 4
| class="col-m" style="text-align:right" | Sustainability
| class="col-xs" style="text-align:right" | 44
|}
</div>
* This slide presents the table of contents for the appendix or additional disclosures section. <sup>p. 36</sup>
* The slide is marked as "GIE_AXA_Confidential". <sup>p. 36</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-s" style="text-align:right" | Share
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|}
</div>
* '''Well diversified across lines of business and geographies''' <sup>p. 37</sup>
* '''Leading market positions across lines''' <sup>p. 37</sup>
** '''Top 3 globally''' in:
*** Multinational Programs² <sup>p. 37</sup>
*** Marine³ <sup>p. 37</sup>
*** Fine Art & Specie⁴ <sup>p. 37</sup>
* '''Managing the cycle to deliver consistent profitability''' <sup>p. 37</sup>
** (scatter plot) '''Relative positioning of business lines''' by Profitability (Y-axis) and Ex-price growth % (X-axis) <sup>p. 37</sup>:
*** '''Property''': Highest profitability and highest ex-price growth <sup>p. 37</sup>
*** '''Specialty''': High profitability and high ex-price growth <sup>p. 37</sup>
*** '''Casualty''': Medium profitability and medium ex-price growth <sup>p. 37</sup>
*** '''Professional lines''': Lowest profitability and lowest ex-price growth <sup>p. 37</sup>
* '''Footnotes''': 1. Including Cyber; 2. Source: McKinsey; 3. Source: Aon, Guy Carpenter, and Global Market Insights; 4. Source: Industry Research Biz (January 2026) <sup>p. 37</sup>
<div style="overflow-x:auto">
=== P&C | Focus on Reserves ===
{| class="wikitable"
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
* (barBusiness chart)diversification '''Claimsis reserveswell ratio'''balanced (Netacross undiscountedlines claimsof reservesbusiness /and Net earned premiums)geographies <sup>p. 3837</sup>
** '''IFRS4Market basis''':leadership FY18positions 179%,AXA FY19XL 185%,in FY20the 193%,top FY213 188%,globally FY22 189%for <sup>p. 3837</sup>:
** '''IFRS17Multinational basis''': FY22 198%, FY23 195%, FY24 180%, FY25 175%Programs <sup>p. 3837</sup>
** Marine <sup>p. 37</sup>
* (bar chart) '''Technical reserves ratio''' (Net undiscounted technical reserves¹ / Net earned premiums) <sup>p. 38</sup>
** '''IFRS4Fine basis''':Art FY18& 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227%Specie <sup>p. 3837</sup>
** '''IFRS17Cycle basis''':management FY22is 234%,utilized FY23to 232%,deliver FY24consistent 216%, FY25 210%profitability <sup>p. 3837</sup>
* ¹Includes''Property'': nethigh undiscountedprofitability, claimshigh reservesex-price and unearned premium reservesgrowth <sup>p. 3837</sup>.
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
=== P&C | 2026Focus Simplifiedon Group Nat Cat Reinsurance Program 1reserves ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment capacityClaims and retentiontechnical byreserves perilratios <sup>p. 3938</sup>
! style="text-align:left" | EUR million%
! class="col-s" style="text-align:right" | CapacityFY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" | 195
| style="text-align:right" | 180
| style="text-align:right" | 175
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection <sup>p. 39</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 4,000600m
| style="text-align:right" | 6004.0bn
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2,100450m
| style="text-align:right" | 4502.1bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2,100400m
| style="text-align:right" | 4002.1bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1,200600m
| style="text-align:right" | 6001.2bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1,200600m
| style="text-align:right" | 6001.2bn
|-
| style="text-align:left" | Per other perils
| style="text-align:right" | —400m
| style="text-align:right" | 400Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* All figures are in Euro.
* (diagram) ''Reinsurance segment'' (illustrative):
* Stable retention levels will be maintained in 2026 as in 2025.
* (diagram)Covered '''Reinsurance segmentvia (illustrative)''' is comprised of Alternative Capital & Cat Bonds'' <sup>p. 39</sup>
* The program excludes local reinsurance covers.
* There is varying retention between Mexico (MX) and North America (NA): EUR 400m for MX and EUR 600m for NA.
* "Other perils" include Turkey earthquake, other Europe and NA perils, South America Earthquake, and a series of other secondary perils. Capacity varies by peril type.
* '''EU Windstorm''': Capacity EUR 4.0bn, Retention EUR 600m <sup>p. 39</sup>.
* '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup>.
* '''Europe Earthquake''': Capacity EUR 2.1bn, Retention EUR 400m <sup>p. 39</sup>.
* '''NA Hurricane''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>.
* '''NA Earthquake''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>.
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
Caption: Natural catastrophe charge scenarios and expectations <sup>p. 40</sup>
* '''Group underlying earnings deviation to average Nat Cat charges in 2026'''
* (net of reinsurance, post-tax)
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 <sup>p. 40</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:rightleft" | DeviationReturn period / probability percentile
! class="col-s" style="text-align:right" | EUR billion
|-
| style="text-align:left" | '''More severe years (negative deviation in ca. 40% of cases)'''
| style="text-align:right" | —
|-
| style="text-align:left" | 1/20y event (95th percentile)
| style="text-align:right" | -1.2
|-
| style="text-align:left" | 1/10y event (90th percentile)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 1/5y event (80th percentile)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | '''Median (50th percentile)'''
| style="text-align:right" | +0.1
|-
| style="text-align:left" | '''Less severe years1/5y (positive deviation in ca. 60% of20th casespercentile)'''
| style="text-align:right" | —
|-
| style="text-align:left" | 1/5y event (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y event (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y event (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
* '''Average Expected Nat Cat charges'''
* (net of reinsurance, pre-tax)
<div style="overflow-x:auto">
{| class="wikitable"
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-xs" style="text-align:rightleft" | 2025Year
! class="col-xss" style="text-align:right" | 2026EUR billion
! class="col-s" style="text-align:right" | Estimated impact on GEP
|-
| style="text-align:left" | Average Expected Nat Cat charges2025
| class="col-xss" style="text-align:right" | 2.6
| class="col-xss" style="text-align:right" | 2ca.7 4.5%
|-
| style="text-align:left" | Estimated impact on GEP2026
| class="col-xss" style="text-align:right" | ca2. 4.5%7
| class="col-xss" style="text-align:right" | ca. 4.5%
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* All figures in EUR billion, net of reinsurance.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost is defined as the Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. The deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
=== Table of contents ===
* 1. Debt and Invested Assets, p.31 <sup>p. 41</sup>
* 2. Additional P&C disclosures, p.36 <sup>p. 41</sup>
* 3.''Debt Additionaland IFRS17Invested disclosures, p.41Assets'' <sup>p. 4131</sup>
* 4.''Additional Sustainability,P&C p.44disclosures'' <sup>p. 4136</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== P&C | Margin analysis ===
* (flow) The slide presents a flow diagram detailing the components of the P&C Technical and Financial results, which sum to Underlying Earnings before tax. All changes are versus FY24 at constant FX <sup>p. 42</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C Underlyingmargin Earningsanalysis buildup,and FY25underlying vsearnings FY24FY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change vs FY24
|-
| style="text-align:left" | '''Current Accident Year Undiscounted Technical Result'Margin''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Undiscounted Technical Margin
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" | ''Current Accident Year Discounting''
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" | '''FinancialInvestment Result'Income''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | ''Insurance Finance Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | '''8,040'''
| style="text-align:right" | '''+681'''
|-
| style="text-align:left" | Tax
| style="text-align:right" | -10
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | '''5,872'''
| style="text-align:right" | '''+501'''
|}
</div>
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* '''Supporting Metrics & Details:'''
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
** Gross Earned Premiums: EUR 57,656m, +6%
** Current''Discounting Accidentratio'' Year-3.5% Undiscounted(+0.0pt in Combined Ratio: 95.2%,points) -1<sup>p.0pt 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
*** of which Nat Cats: 3.4%, -0.4pt
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
** Discounting Ratio (in Combined Ratio points): -3.5%, +0.0pt
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
** Current Accident Year Net Claims reserves: EUR 19.0bn
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
** Duration: 4.0 years
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
** Current Accident Year Discount rate: 2.8%
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** PYD ratio: -1.1%, +0.7pt
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** FY25 Average Assets: EUR 115bn
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
** Asset book yield: 3.5%
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** FY25 Reinvestment yield on fixed income assets: 4.3%
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
** FY24 Reserves at locked-in rate: EUR 71bn
** Liability book yield: 1.9%
** Underlying Earnings Growth vs. FY24 (at constant FX): +9%
** 2026e Insurance Finance Expenses (pre-tax): ~-EUR 1.4bn
<div style="overflow-x:auto">
{| class="wikitable"
|+ FY25 sensitivity to Current Accident Year discount rate changes <sup>p. 42</sup>
! style="text-align:left" | Scenario
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | +25bps
| class="col-s" style="text-align:right" | +EUR 0.2bn
|-
| style="text-align:left" | -25bps
| class="col-s" style="text-align:right" | -EUR 0.2bn
|}
</div>
* ''Based on a parallel shift of the full-year average yield curve used for discounting FY25 current accident year net reserve.''
<div style="overflow-x:auto">
{| class="wikitable"
|+ Sensitivity of 2026e Insurance Finance Expenses <sup>p. 42</sup>
! style="text-align:left" | Scenario
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | +25bps
| class="col-s" style="text-align:right" | ~-EUR 50m
|-
| style="text-align:left" | -25bps
| class="col-s" style="text-align:right" | ~+EUR 50m
|}
</div>
* ''Sensitivity to changes in 2025 current AY Discount.''
=== L&H | Margin analysis ===
* Includes''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* Changes''Short-term versustechnical FY24margin'' at+EUR constant60m FXto EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* Reinvestment''Gross yieldearned onpremiums'' fixed+10% incometo assetsEUR 17,416m <sup>p. 43</sup>.
* Incl.''All recaptureyear ofcombined Layaratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ LifeTechnical &and Healthfinancial Underlyingresults Earningsin buildupEuro million, FY25 vs FY24pre-tax <sup>p. 43</sup>
! style="text-align:left" | EURTechnical millionand unlessFinancial otherwise mentionedResults
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change vs FY24
|-
| style="text-align:left" | '''Technical Result'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term Technical Margin
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|-
| style="text-align:left" | '''Financial Result'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup>
! style="text-align:left" | Underlying Earnings
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | '''4,229'''
| style="text-align:right" | '''+205'''
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | +65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -51
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | '''3,501'''
| style="text-align:right" | '''+219'''
|}
</div>
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
* '''Supporting Metrics & Details:'''
** Gross Earned Premiums: EUR 17,416m, +10%
** All Year Combined Ratio: 97.2%, -0.1pts
** CSM release: EUR 2,954m, +EUR 215m
** Technical experience: -EUR 150m, -EUR 58m
** FY25 Average Assets: EUR 98bn
** Asset book yield: 2.5%
** FY25 Reinvestment yield¹: 3.8%
** FY24 Reserves at locked-in rate: EUR 62bn
** Liability book yield: 2.5%
** Underlying Earnings Growth vs. FY24 (at constant FX): +7%
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Keykey Sensitivitiessensitivities in Euro billion <sup>p. 43</sup>
! style="text-align:left" | EUR billionSensitivity
! class="col-s" style="text-align:right" | Impact on CSM
|-
| style="text-align:left" | '''Baseline'''
| style="text-align:right" | '''33.3'''
|-
| style="text-align:left" | Interest rates +50bps
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.87
|-
| style="text-align:left" | Equities +25%
</div>
=== Table of contents ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and Private Credit Assets (100%) <sup>p. 43</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | % of total G/A portfolio
! class="col-m" style="text-align:right" | Details
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | EUR 6bn Dutch mortgages, NHG guaranteed; EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | Strong diversification with EUR 8m average ticket; Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% participating
|}
</div>
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 43</sup>
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 43</sup>
* (flow) '''Underlying Earnings before tax''' <sup>p. 43</sup>
* 1. ''Debt and Invested Assets, p.31'' <sup>p. 4431</sup>
* 2. ''Additional P&C disclosures, p.36'' <sup>p. 4436</sup>
* 3. ''Additional IFRS17 disclosures, p.41'' <sup>p. 4441</sup>
* 4. ''Sustainability, p.44'' <sup>p. 44</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ SustainabilityESG targets and 2025 performanceachievements <sup>p. 45</sup>
! style="text-align:left" | MetricCategory
! class="col-sm" style="text-align:right" | Target
! class="col-sm" style="text-align:right" | 2025Achieved Resultin 2025
|-
| style="text-align:left" | '''AsClimate atransition Global Investor'''financing
| class="col-sm" style="text-align:right" | —EUR 5bn per year
| class="col-sm" style="text-align:right" | —EUR 6.4bn
|-
| style="text-align:left" | ClimateCommunity transitionresilience financing (per year)
| class="col-sm" style="text-align:right" | €5bn>EUR 500m per year
| class="col-sm" style="text-align:right" | €6EUR 1.4bn
|-
| style="text-align:left" | CommunityTransition resilience financingunderwriting (percumulative year2024-2026)
| class="col-sm" style="text-align:right" | >€500mEUR 6bn in P&C GWP
| class="col-sm" style="text-align:right" | €1EUR 4.4bn6bn
|-
| style="text-align:left" | '''AsClimate aadaptation Globalsolutions Insurer'''(cumulative 2024-2026)
| class="col-sm" style="text-align:right" | —>20,000
| class="col-sm" style="text-align:right" | —19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | P&C GWP for transition underwriting (cumulative 2024-2026)
| class="col-s" style="text-align:right" | €6bn
| class="col-s" style="text-align:right" | €4.6bn
|-
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026)
| class="col-s" style="text-align:right" | >20,000
| class="col-s" style="text-align:right" | 19,698
|-
| style="text-align:left" | Inclusive insurance customers
| class="col-sm" style="text-align:right" | >20m by 2026
| class="col-sm" style="text-align:right" | 20.6m
|-
| style="text-align:left" | '''As a Company'''
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Employees trained on climateClimate adaptation (cumulative 2024-2026)training
| class="col-sm" style="text-align:right" | >80,000 employees by 2026
| class="col-sm" style="text-align:right" | 46,420
|-
| style="text-align:left" | Net-ZeroCarbon contributionemissions (vs 2019)reduction
| class="col-sm" style="text-align:right" | -50% by 2030
| class="col-sm" style="text-align:right" | -64% against 2019
|-
| style="text-align:left" | Employee volunteering
| class="col-sm" style="text-align:right" | 50% of employees by 2026
| class="col-sm" style="text-align:right" | 56%
|}
</div>
* '''Climate transition financing''': The scope covers corporate and sovereign debt, real estate, and private assets, with a timeframe per annum through 2030 <sup>p. 45</sup>.
* '''Community resilience financing''': The scope covers corporate and sovereign debt, real estate, and private assets, with a timeframe per annum through 2030 <sup>p. 45</sup>.
* '''P&C GWP for transition underwriting''': The scope includes AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL <sup>p. 45</sup>.
* '''Climate adaptation solutions & services''': The target was revised in 2025 from >9,000 to >20,000 due to strong support for these services in 2024 and 2025 <sup>p. 45</sup>.
** The scope includes the commercial lines portfolio of AXA France, Germany, Switzerland, UK, Belgium, Hong Kong, Mexico, and AXA XL <sup>p. 45</sup>.
** Services include training/education, risk assessment/awareness, gap analysis, prevention/adaptation solutions, and/or crisis management/remediation response <sup>p. 45</sup>.
* '''Inclusive insurance customers''': This covers low-income to mass market segments in emerging markets and modest income segments in mature markets <sup>p. 45</sup>.
* '''Employees trained on climate adaptation''': Training is completed under the AXA Sustainability Academy, with a cumulative timeframe of 2024-2026 <sup>p. 45</sup>.
* '''Net-Zero contribution''':
** The emissions scope covers energy (Scopes 1 and 2), car fleet, and business travel, with a timeframe of 2019-2030 <sup>p. 45</sup>.
** Offsetting residual emissions will use carbon credits from projects that capture and store atmospheric carbon, such as restorative agriculture, forest restoration, or carbon capture and storage <sup>p. 45</sup>.
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup>.
=== Sustainability Performance & Ratings ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings, 2025 <sup>p. 46</sup>
! style="text-align:left" | Rating Agency
! class="col-ms" style="text-align:right" | 2025 Score/Rating
|-
| style="text-align:left" | S&P Global (Dow Jones Best-in-Class Europe & World indices)percentile
| class="col-ms" style="text-align:right" | 97th percentile
|-
| style="text-align:left" | MSCI
| class="col-ms" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-ms" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-ms" style="text-align:right" | 17.0, - Low risk
|-
| style="text-align:left" | FTSE Russell (FTSE4Good Index Series)
| class="col-ms" style="text-align:right" | 4.3/5
|}
</div>
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results are as of February 6th, 2026 <sup>p. 46</sup>.
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
* '''France''': scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''': scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''': scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': <sup>p.scope 47</sup>includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** China''Africa'': L&S,Morocco Thailand(insurance activities L&Sand holding), theNigeria Philippines(insurance L&Sactivities and P&Cholding), Indonesia L&S and IndiaEgypt (Lifeinsurance activities disposed on March 11, 2024 and holding) businesses which are fully consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa'EME-LATAM'': MoroccoMexico (insurance activities), andColombia holding)(insurance andactivities), NigeriaBrazil (insurance activities and holding), Egyptand Türkiye (insurance activities and holding) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to net income <sup>p. 47</sup>.
** ''AXA Mediterranean Holdings'' <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated as well as Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** ''Transversal & Other'' scope includes AXA MediterraneanAssistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* ''AXA Investment Managers'' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* ''Accounting standards''AXA Investmentcomparative Managersfigures (untilgoing Julyback 1,to 2025)''':2023 includesare AXAunder InvestmentIFRS17/9 Managers, Selectstandards (previouslyeffective referredJanuary to as1, Architas2023); andfigures Capzaprior whichto are2023 fullyhave consolidatednot andbeen Asianrestated joint ventures whichand are consolidatedpresented under the equity methodIFRS4 <sup>p. 47</sup>.
* Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
=== Glossary ===
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>.
* '''Contractual Service Margin (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>.
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>.
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>.
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* ''New Business Value (NBV)'': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* ''New Business Contractual Service Margin (NB CSM)'': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
* '''New Business Contractual ServiceValue Marginmargin (NBNBV CSMmargin)''': a componentratio of the(i) carryingNBV, amount ofrepresenting the assetvalue or liability forof newly issued insurance contracts during the periodcurrent year, representing the unearned profit to be recognized as insurance contract services are(ii) providedPVEP <sup>p. 48</sup>.
* ''Operating variance'': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>.
* ''Present value of expected premiums (PVEP)'': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes <sup>p. 48</sup>. Operating variance is net of reinsurance <sup>p. 48</sup>.
* ''Technical experience'Present': valueconsists of expectedthe premiumsimpacts (PVEP)''':on the newunderlying businessearnings volume,of equal to(i) the presentdifference value atbetween the timeexpected ofand incurred issuecash-flows of the totaldefined premiumsperiod, expected(ii) tothe berisk receivedadjustment overrelease, (iii) the policychanges termin <sup>p.onerous 48</sup>.contracts, PVEPand is(iv) discountedthe atother thelong-term referenceelements interestwhich rateare andmainly PVEPcomposed isof Groupnon-attributable shareexpenses <sup>p. 48</sup>.
* ''Underlying return on in-force'': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* ''Closing slide'' for the AXA Full Year 2025 Earnings presentation, dated February 26, 2026 <sup>p. 49</sup>.
* Thank you <sup>p. 49</sup>.
* Full Year 2025 Earnings <sup>p. 49</sup>.
* February 26, 2026 <sup>p. 49</sup>.
== Abbreviations ==
* '''AA''': Senior Securedbond rating
* '''AAA''': PrimeSenior bond rating
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des Marchésmarchés Financiersfinanciers
* '''APAC''': Asia-Pacific
* '''AXA IM''': AXA Investment Managers
* '''AXA UK'XL'': AXA UnitedCorporate Solutions and XL KingdomCatlin
* '''AY''': Accident Year
* '''BBA''': BalanceBenefit-Sheet BasedBearing AccountingAccount
* '''CDP''': Carbon Disclosure Project
* ''CLO'': Collateralized Loan Obligation
* '''CH''': Switzerland
* '''CLO'CRE'': CollateralizedCommercial LoanReal ObligationEstate
* '''CRE'CSA'': CommercialCorporate RealSustainability EstateAssessment
* ''CSM'': Contractual Service Margin
* '''CSA''': Corporate Sustainability Assessment
* '''CSM'CY'': Contractual ServiceCalendar MarginYear
* '''CY'DPS'': CurrentDividend Per YearShare
* '''DE'EME'': GermanyEmerging Markets
* '''DPS'EOF'': DividendEligible PerOwn ShareFunds
* '''EME'EPS'': EmergingEarnings Per MarketsShare
* ''ESG'': Environmental, Social, and Governance
* '''EOF''': Eligible Own Funds
* ''ESMA'': European Securities and Markets Authority
* '''EPS''': Earnings Per Share
* ''EU'': European Union
* '''ESG''': Environmental, Social, and Governance
* ''EUR'': Euro
* '''ESMA''': European Securities and Markets Authority
* '''EU'FX'': EuropeanForeign UnionExchange
* '''FTSE'GAAP'': FinancialGenerally TimesAccepted StockAccounting ExchangePrinciples
* '''FX'GBP'': ForeignGreat British ExchangePound
* ''GEP'': Gross Earned Premium
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP'GWP'': Gross EarnedWritten Premiums
* '''GF'HKD'': GrandfatheredHong Kong Dollar
* '''GWP'HY'': Gross WrittenHigh PremiumsYield
* '''HKD'IFE'': HongInsurance KongFinance DollarExpenses
* ''IFRS'': International Financial Reporting Standards
* '''HY''': High Yield
* '''IFE'IG'': Insurance FinanceInvestment ExpensesGrade
* ''JPY'': Japanese Yen
* '''IFRS''': International Financial Reporting Standards
* '''IG'LATAM'': InvestmentLatin GradeAmerica
* '''JPY'LFL'': Japanese YenLike-for-Like
* '''LATAM'LTV'': Latin AmericaLoan-to-Value
* ''MSCI'': Morgan Stanley Capital International
* '''LTV''': Loan-To-Value
* ''NA'': North America
* '''MSCI''': Morgan Stanley Capital International
* ''NB CSM'': New Business Contractual Service Margin
* '''MX''': Mexico
* '''NA'NBV'': NorthNew Business AmericaValue
* ''NHG'': Nationale Hypotheek Garantie
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV'NPS'': NewNet BusinessPromoter ValueScore
* '''NHG'OCI'': NationaleOther HypotheekComprehensive GarantieIncome
* '''NPS'PAA'': NetParticipating PromoterAccount ScoreAgreement
* '''OCI'PE'': Other ComprehensivePrivate IncomeEquity
* '''PAA'PVEP'': PremiumPresent Value of AllocationExpected ApproachProfits
* '''PE'PYD'': PrivatePrior Years' Reserve EquityDevelopment
* ''RCG'': Reinsurance Capital Generation
* '''PVEP''': Present Value of Expected Profits
* '''PYD'ROE'': Prior Years'Return Reserveon DevelopmentEquity
* '''RCG'SCR'': Reclassification ofSolvency Capital GainsRequirement
* '''ROE'SHE'': Return OnShareholders' Equity
* '''SCR'SME'': SolvencySmall and CapitalMedium-sized RequirementEnterprises
* ''TVOG'': Time Value of Options and Guarantees
* '''SHE''': Shareholders' Equity
* ''UEPS'': Underlying Earnings Per Share
* '''SME''': Small and Medium-sized Enterprises
* ''UK'': United Kingdom
* '''TVOG''': Time Value of Options & Guarantees
* '''UE'US'': UnderlyingUnited EarningsStates
* '''UEPS'VAT'': Underlying EarningsValue PerAdded ShareTax
* '''UK'VFA'': UnitedVariable Fee KingdomApproach
* '''US''': United States
* '''VAT''': Value Added Tax
* '''VFA''': Variable Fee Approach
|